Pharma Industry Outlook with Networking Reception

Exclusive to DCAT Member Companies

Date/Time: Monday, March 21, 2022 - 2:30 PM to 4:30 PM
Location: InterContinental Barclay - Grand Ballroom
Networking & Coffee for registrants: Doors open at 2:00 PM
Networking Reception for registrants: 4:30 to 6:00 PM (Empire I; across from Grand Ballroom)


  • Graham Lewis, Vice President of Global Pharma Strategy, IQVIA
  • Jim Miller, Consultant & Content Advisor, Drug, Chemical & Associated Technologies Association (DCAT)

Program Highlights

  • Latest market data on Bio/Pharmaceutical industry performance
  • Growth prospects in therapeutic and geographical markets
  • CDMO/CMO financial overview: valuations, key M&A, & sector outlook


How did the Bio/Pharmaceutical industry perform in 2021, and what can be expected in 2022 and the near-term? Graham Lewis, Vice President of Global Pharma Strategy, IQVIA, a business intelligence firm regarded as the gold standard for Bio/Pharmaceutical market analysis, will provide the latest market data and trends for:

  • Innovator and generic drugs
  • Leading therapeutic sectors: pipelines and commercial products
  • Growth prospects in developed and emerging markets.

Plus, a CDMO/CMO outlook, including a financial overview: valuations, key M&A, & sector outlook, featuring bio/pharmaceutical outsourcing industry expert, Jim Miller, Consultant and Content Advisor, DCAT.

Why is DCAT’s Pharma Industry Outlook the most popular DCAT Week program for more than 15 years? DCAT Member Companies agree it is the Number 1 resource for Bio/Pharmaceutical market data and analysis that provides a comprehensive, yet easy-to-digest analysis of industry performance crucial for your decision-making. PLUS... a great opportunity to share your thoughts on what you heard at the program and network with colleagues.

Networking Reception

Thank you to our sponsor, Samsung Biologics. Pharma Industry Outlook registrants are invited to attend a networking reception following the program, from 4:30-6:00 PM, in Empire I (across from the Grand Ballroom, InterContinental Barclay Hotel)

Who Should Attend

  • C-suite and senior to mid-level executives of Bio/Pharmaceutical Companies, including those involved in sourcing, procurement, supply management, and manufacturing.
  • C-suite and senior to mid-level executives of CDMOs/CMOs and other suppliers, including those in business development, sales, marketing, and operational functions in support of Bio/Pharmaceutical development and manufacturing.

Pricing and Registration

The DCAT organization is pleased to offer timely and topical education sessions during DCAT Week. Compared to similar programs found in the industry’s marketplace, our program fees are deeply discounted for employees of DCAT Member Companies. 

Please note: DCAT Week 2022 programs are available to employees of DCAT Member Companies only. Not sure if your company is a DCAT member? Click here or call DCAT at 1-609-208-1888.

  • DCAT Member Company Price: $369.00

Online registration has closed. Onsite registration for education programs and networking events is available Monday, March 21, through Thursday, March 24, in the DCAT Office (InterContinental Barclay, Barclay Salon). Registrations requiring payment can only be processed by credit card; cash, checks, and requests for an invoice will not be accepted.

Please review our Cancellation and Refund Policy here.

Attending DCAT Week Education Programs

Vaccine Mandates Lifted in New York City - Effective March 7, 2022, Key to NYC COVID-19 protocols have been lifted. Proof of vaccination will no longer be required to enter Official DCAT Week Hotels and DCAT hosted areas of the InterContinental, Lotte NY Palace, and Hilton Hotels during DCAT Week. Please review our updated COVID-19 protocols here. See here for more Health & Safety Protocols at DCAT Week 2022 and here for DCAT Member Name Badge Policy.

All materials provided to registrants (including slides, reports, and presented information) are only for their reference. Registrants may not copy, photograph, or redistribute any materials, and they are responsible for any claim for violations of copyright or other intellectual property rights.